Stocktoria
Akari Therapeutics Plc AKTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-01-31
Akari Therapeutics Plc statistics & valuation
Market cap$10.9M
P / B0.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -36.1% | -39.1% | -229.8% | -128.3% | -149.6% |
| Return on equity | -61.1% | -89.0% | 4370.3% | -991.0% | -313.7% |
| Current ratio | 0.44 | 0.15 | 0.95 | — | — |
Source: SEC EDGAR filings · CIK 0001541157 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.